In particular, as anticipated, we found that the effect of AZD5363 on pro‐angiogenic tumour signalling revealed levels of HIF‐1α were significantly reduced in drug‐treated tumours, as were tumour‐derived VEGF levels. This evidence concerns the gene HIF1A and neoplasm.